Newborn Screening Panel 8 Test Price 560 AED– DNA Labs UAE

Introduction to Newborn Screening

The birth of a child is a joyous occasion, but it also brings responsibilities, including ensuring the baby’s health and well-being. Early detection of potential health issues is crucial, and the Newborn Screening Panel 8 Test offers parents in the UAE a comprehensive solution. This test screens for multiple metabolic and genetic disorders, providing critical insights that can guide early intervention and treatment.

Newborn Screening Test Procedure

The Newborn Screening Panel 8 Test is designed to detect a range of genetic and metabolic disorders in newborns. The procedure is straightforward and minimally invasive, ensuring the safety and comfort of the newborn. Here’s how the process works:

1. Sample Collection: Typically performed within the first 24 to 48 hours after birth, a few drops of blood are collected from the newborn’s heel. This procedure, known as a heel prick, is quick and causes minimal discomfort to the baby.
2. Laboratory Analysis: The blood sample is sent to a specialized laboratory for analysis. Advanced techniques are used to screen for a variety of disorders by examining the presence and concentration of specific substances in the blood.
3. Results Interpretation: Trained geneticists and pediatricians interpret the results. If any abnormalities are detected, they provide a detailed report explaining the findings and their potential implications.
4. Follow-Up: In cases where the test indicates a possible disorder, healthcare providers will discuss the results with the parents and recommend further diagnostic testing or immediate intervention as necessary.

Newborn Screening Test List

The Newborn Screening Panel 8 Test covers a broad spectrum of disorders. Here is a detailed list of conditions typically included in the panel:

1. Phenylketonuria (PKU): A metabolic disorder affecting the body’s ability to process the amino acid phenylalanine, leading to intellectual disabilities if untreated.
2. Congenital Hypothyroidism: A condition where the thyroid gland doesn’t produce enough hormones, crucial for growth and brain development.
3. Sickle Cell Disease: A genetic disorder causing red blood cells to assume a sickle shape, leading to anemia, pain, and other serious complications.
4. Cystic Fibrosis: A genetic disorder affecting the respiratory and digestive systems, leading to severe lung infections and digestive issues.
5. Galactosemia: A metabolic disorder affecting the ability to process galactose, a sugar found in milk, leading to liver damage, intellectual disability, and other issues.
6. Maple Syrup Urine Disease (MSUD): A metabolic disorder affecting the breakdown of certain amino acids, leading to severe neurological damage if untreated.
7. Biotinidase Deficiency: A metabolic disorder affecting the body’s ability to recycle the vitamin biotin, leading to neurological and skin problems.
8. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): A disorder affecting the body’s ability to convert certain fats to energy, especially during periods without food.

Benefits of the Newborn Screening Panel 8 Test

The Newborn Screening Panel 8 Test offers several significant benefits:

1. Early Detection and Intervention: Early diagnosis allows for prompt treatment and management, preventing severe health problems and improving the child’s quality of life.
2. Comprehensive Screening: The test covers a wide range of disorders, providing a thorough health check for the newborn.
3. Non-Invasive Procedure: The test requires only a small blood sample from a heel prick, causing minimal discomfort to the baby.
4. Peace of Mind for Parents: Knowing that their baby has been screened for critical health conditions provides parents with peace of mind and confidence in their child’s health.

Choosing the Right Facility for Newborn Screening in the UAE

When selecting a facility for the Newborn Screening Panel 8 Test, consider the following factors:

1. Accreditation and Certification: Ensure the facility is accredited and follows international standards for newborn screening.
2. Experienced Healthcare Providers: Choose a facility with experienced pediatricians and laboratory technicians who specialize in newborn care and genetic testing.
3. Comprehensive Support Services: Opt for facilities that offer follow-up care and genetic counseling to help parents understand and manage the test results.
4. State-of-the-Art Technology: Ensure the facility uses advanced technology for accurate and reliable testing.
5. Patient-Centered Care: Look for facilities that prioritize patient comfort and provide clear communication throughout the screening process.
   

   Test Details

   The Newborn Screening Panel 8 Test is a comprehensive screening test performed on newborn babies to detect certain genetic, metabolic, and hormonal disorders. It includes testing for eight different conditions:

   1. Phenylketonuria (PKU): This is a genetic disorder in which the body cannot break down an amino acid called phenylalanine, leading to a buildup of this substance in the blood.
   2. Congenital Hypothyroidism: This condition occurs when the thyroid gland does not produce enough thyroid hormone, which is important for growth and development.
   3. Galactosemia: This is a metabolic disorder in which the body is unable to break down a sugar called galactose, leading to a buildup of this substance in the blood.
   4. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder in which the body is unable to break down certain amino acids, leading to a buildup of these substances in the blood and urine.
   5. Homocystinuria: This is a genetic disorder in which the body cannot break down an amino acid called homocysteine, leading to a buildup of this substance in the blood.
   6. Biotinidase Deficiency: This is a genetic disorder in which the body cannot break down a vitamin called biotin, leading to a deficiency of this vitamin.
   7. Congenital Adrenal Hyperplasia (CAH): This is a hormonal disorder in which the adrenal glands do not produce enough cortisol and aldosterone, leading to an imbalance of hormones in the body.
   8. Sickle Cell Disease: This is a genetic disorder in which the red blood cells are abnormally shaped, leading to a decreased ability to carry oxygen and causing various health problems.

   The Newborn Screening Panel 8 Test is typically performed within the first few days of a baby’s life and involves a blood sample taken from a heel prick. Early detection of these disorders allows for prompt treatment and management, which can prevent or minimize the long-term complications associated with these conditions.

   Test Cost and Sample Requirements

   The cost of the Newborn Screening Panel 8 Test is AED 560.0. To perform the test, we require a sample of 1 drop of heel prick blood on 3 spots of filter paper. The filter paper is available from LPL. The sample must be shipped refrigerated and should not be frozen. Clinical details and drug history must accompany the sample to ensure accurate analysis and interpretation of the results.

   Report Delivery

   The sample for the Newborn Screening Panel 8 Test should be submitted on Mondays, Wednesdays, or Fridays by 9 am. The report will be delivered the next day.

   Method and Test Type

   The Newborn Screening Panel 8 Test is performed using the Fluoroimmunoassay and Capillary Electrophoresis methods. This ensures accurate and reliable results for the detection of inborn errors of metabolism.

   Referring Doctors

   The Newborn Screening Panel 8 Test can be ordered by Pediatricians, Physicians, and Gynecologists. We work closely with healthcare professionals to provide the best care for newborns and their families.

   Pre Test Information

   Clinical details and drug history must accompany the sample to ensure accurate analysis and interpretation of the results. This information is crucial for a comprehensive understanding of the baby’s health and to guide further medical interventions if necessary.

Conclusion

The Newborn Screening Panel 8 Test is an essential tool for ensuring the health and well-being of newborns in the UAE. By providing early detection of serious genetic and metabolic disorders, this test enables timely intervention and treatment, greatly improving outcomes for affected infants. For parents, choosing the right facility ensures that their newborn receives the best possible start in life, with comprehensive screening and support services tailored to their needs. With the Newborn Screening Panel 8 Test, parents can have confidence in their child’s health and future.

Welcome to DNA Labs UAE, a leading genetic lab in the United Arab Emirates. We offer a comprehensive range of tests, including the Newborn Screening Panel 8 Test. This test is designed to detect certain genetic, metabolic, and hormonal disorders in newborn babies.